Elizabeth T. Cirulli

Nov 25, 2024 | jamanetwork.com | Matthew Levy |San Mateo |Elizabeth T. Cirulli |Patricia Rodríguez

Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or Obesity Patricia J. Rodriguez, PhD; Brianna M. Goodwin Cartwright, MS; Samuel Gratzl, PhD; Rajdeep Brar, MD; Charlotte Baker, DrPH; Ty J. Gluckman, MD; Nicholas L. Stucky, MD Semaglutide vs Tirzepatide Dosages for Weight Loss—Reply Patricia J. Rodriguez, PhD, MPH; Ty J.

Mar 20, 2024 | cell.com | Elizabeth T. Cirulli |Alexandre Bolze |Daniel Judge |Joseph Grzymski

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Dec 28, 2023 | jamanetwork.com | Alexandre Bolze |San Mateo |Elizabeth T. Cirulli |Catherine Hajek

Key PointsQuestion  Can genetic information identify women for whom it is safe to delay mammogram screening? Findings  In this case-control study of 25 591 women, 2338 (9.1%) were classified as having low genetic risk for breast cancer; these women exhibited significantly later onset of breast cancer compared with average-risk or high-risk counterparts, indicating a potential to defer mammogram screening by 5 to 10 years.